Efficacy of Heterologous Vaccination Using Virus-Like Particles and Vaccinia Virus Containing MIC8 and AMA1 Proteins of .

Vaccines (Basel)

Department of Medical Zoology, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

() infection causes serious diseases in immunocompromised patients and causes congenital toxoplasmosis in infants. microneme protein 8 (MIC8) and apical membrane antigen 1 (AMA1) are essential proteins involved in parasitic invasion. In this study, we generated virus-like particles (VLPs) and recombinant vaccinia virus (rVV) containing MIC8 or AMA1 proteins. Vaccine efficacy was evaluated in mice (BALB/c) upon challenge infection with ME49. Intramuscular immunization with heterologous vaccines (rVV + VLPs; rVV for prime and VLPs for boost) elicited -specific IgG antibody responses in mice. Four weeks after the boost, all mice were orally challenged with ME49, and protective immunity was assessed. The responses of antibody-secreting cells for IgG2a and IgG2b and those of memory B cells and CD4+ and CD8+ T cells were higher in the rVV + VLP group than in the VLP + VLP group. The rVV + VLP group exhibited a significant reduction in cyst count in the brain. These findings indicate that heterologous vaccination with vaccinia viruses and VLPs improves vaccine efficacy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12389783PMC
http://dx.doi.org/10.3390/vaccines13080862DOI Listing

Publication Analysis

Top Keywords

vlp group
12
heterologous vaccination
8
virus-like particles
8
vaccinia virus
8
mic8 ama1
8
ama1 proteins
8
vaccine efficacy
8
rvv vlp
8
rvv
5
efficacy heterologous
4

Similar Publications

Background: Enteroviruses, including Coxsackie B (CVB) viruses, can cause severe diseases such as myocarditis, pancreatitis, and meningitis. Vaccines can prevent these complications, but conserved non-neutralizing epitopes in the viral capsid may limit their effectiveness. The immunodominant PALXAXETG motif, located in the VP1 N-terminus, is a highly conserved region in enteroviruses that elicits non-neutralizing antibody responses.

View Article and Find Full Text PDF

H5N1 influenza virus-like particles based on BEVS induce robust functional antibodies and immune responses.

Virology

August 2025

Changchun Institute of Biological Products Co.,Ltd, Changchun, China; State Key Laboratory of Novel Vaccines for Emerging Infectious Diseases, China National Biotec Group Company Limited, Beijing, China. Electronic address:

Avian influenza virus infections pose a potential pandemic threat. The currently licensed vaccines have inherent limitations, emphasizing the urgent need for improved influenza vaccines. Here, we developed a novel hemagglutinin (HA) virus-like particle (VLP) vaccine candidate through the baculovirus expression vector system (BEVS).

View Article and Find Full Text PDF

Background: The optimal management of distal radius fractures (DRFs) in older patients remains debatable. A knowledge gap exists concerning how to manage fractures with early malalignment during nonoperative treatment. We conducted a prospective, multicenter, and randomized controlled trial to compare nonoperative treatment to operative treatment with volar locking plating (VLP) in the management of primarily malaligned DRFs and DRFs that exhibit early malalignment during nonoperative treatment.

View Article and Find Full Text PDF

Efficacy of Heterologous Vaccination Using Virus-Like Particles and Vaccinia Virus Containing MIC8 and AMA1 Proteins of .

Vaccines (Basel)

August 2025

Department of Medical Zoology, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.

() infection causes serious diseases in immunocompromised patients and causes congenital toxoplasmosis in infants. microneme protein 8 (MIC8) and apical membrane antigen 1 (AMA1) are essential proteins involved in parasitic invasion. In this study, we generated virus-like particles (VLPs) and recombinant vaccinia virus (rVV) containing MIC8 or AMA1 proteins.

View Article and Find Full Text PDF

Protective Efficacy Induced by Virus-like Particles Expressing Dense Granule Protein 5 of .

Vaccines (Basel)

July 2025

Medical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical Science Institute, Core Research Institute (CRI), Kyung Hee University, Seoul 02447, Republic of Korea.

() causes severe disease in immunocompromised individuals and pregnant women, underscoring the urgent need for effective vaccines against toxoplasmosis. The dense granule protein 5 (GRA5) of plays a key role in parasitic cyst formation. This study evaluated the protective immune responses induced by a virus-like particle (VLP) vaccine expressing the -derived antigen GRA5 in a mouse model challenged with the ME49 strain of .

View Article and Find Full Text PDF